Article Text

Download PDFPDF
18F-fluorodeoxyglucose positron-emission tomography/CT and lung involvement in systemic sclerosis

Statistics from Altmetric.com

Footnotes

  • Handling editor Josef S Smolen

  • Presented at This work has been previously presented at a conference and published as a conference abstract in 2018.

  • Contributors SB-R and LTa: contribution to conception and design of the study, interpretation of data, drafting the manuscript and final approval. EC: execution, analysis and interpretation of data, final approval. LTo: analysis and interpretation of data and final approval. CB: drafting the manuscript and final approval. GL, JB, CM, JA and SG: revising the manuscript critically and final approval. AM-P: contribution to conception and design of the study and final approval. AP and MTDC: execution, interpretation of data and final approval. OD and YA: contribution to conception and the design of the study, revising the manuscript critically and final approval. MM-C: contribution to conception and the design of the study, interpretation of data, revising the manuscript critically and final approval.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Patient consent Obtained.

  • Ethics approval As case series, ethics committee approval was not required in accordance with the policy of our institution.

  • Provenance and peer review Not commissioned; externally peer reviewed.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.